GLP-1 drugs are revolutionizing weight loss globally. This post explores the impact of these medications, their potential benefits beyond weight loss, and how to monitor your health on this journey.
On this page
Source Information
Originally published by The Economist.Read the original article →
Keep exploring
More on Ozempic
Articles covering Ozempic dosing, side effects, and clinical updates.

What's the Deal with Peptides? The Hyped Market Under FDA Review
An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.
8 min read
Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program
Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.
8 min read
Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials
Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.
7 min readSame topic: GLP-1 drugs

Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics
Samsung Biologics has announced a major acquisition of PolyPeptide Group AG for $1.8 billion, marking a strategic expansion into the rapidly growing peptide therapeutics market, particularly for GLP-1 drugs.
8 min read
How Iconic Philly Food Brands Are Adapting to Calorie-Conscious Consumers
Philadelphia's iconic food brands are evolving, introducing high-protein and functional food options to cater to the growing number of calorie-conscious consumers, influenced by trends like GLP-1 medications and a desire for healthier choices.
8 min read
Why I Lost Virtually No Weight on Wegovy and Mounjaro
Explore the real-world experience of a patient who spent thousands on GLP-1 injections without significant results, and learn what worked instead.
7 min readMore in Weight Loss

GLP-1 Weight Loss & The Changing Landscape: Navigating Semaglutide & Beyond
The GLP-1 weight loss market is experiencing significant shifts with new leadership and competitive pressures. This article dives into the latest developments surrounding semaglutide, Ozempic, and Wegovy, and explores the broader impact on health and wellness.
4 min read
GLP-1 Weight Loss Drugs: Understanding Safety & Pharmacy Practices
Recent news highlights the importance of safe pharmacy practices in the production of GLP-1 weight loss drugs. Understand the regulations, potential risks, and how to ensure you're getting safe and effective medication.
3 min read
GLP-1 Restrictions: What Michigan's Medicaid Changes Mean for You
Michigan is tightening access to GLP-1 drugs like Ozempic and Wegovy for weight loss under Medicaid. This blog post explains the changes, explores the impact on patients, and discusses alternative approaches to weight management and metabolic health.
4 min read